Company Profile
Vanda Pharmaceuticals Stock Price, News & Catalysts
- Ticker:
- VNDA
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
5.28 USD (-1.86%)
Close
Last updated: August 21, 2026
369M USD
Market cap
Why the stock is moving
As of Aug 21, 2026, VNDA closed down 1.86% at $5.28. No new same-company headline was identified in the current news window.
Company overview
Business overview
Vanda Pharmaceuticals is a specialty pharma company with an emphasis on neuroscience and sleep-related therapies. Its business has long centered on commercial products and selective pipeline development.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Vanda sits in specialty biopharma.
Business Model Characteristics
The company depends on product revenue, label positioning, and the ability to build new assets around a concentrated commercial base.
Position Within the Biotechnology Landscape
Vanda is a commercial specialty-pharma name whose valuation is tied to product durability and pipeline optionality.
Future catalysts
- Vanda’s catalysts are HETLIOZ and Fanapt execution, plus any regulatory or litigation update tied to the sleep franchise. The stock usually moves when the company shows that the commercial base can stay durable.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Vanda Pharmaceuticals (VNDA)?
Vanda Pharmaceuticals (VNDA) most recently closed at 5.28 USD, a -1.86% move versus the previous session.
What is the market cap of Vanda Pharmaceuticals (VNDA)?
Vanda Pharmaceuticals currently has a market capitalization of 369M USD on BioPharmSignal.
What does Vanda Pharmaceuticals do?
Vanda Pharmaceuticals is a specialty pharma company with an emphasis on neuroscience and sleep-related therapies. Its business has long centered on commercial products and selective pipeline development.
On which exchange is VNDA stock listed?
Vanda Pharmaceuticals (VNDA) is associated with NASDAQ, United States, Biopharma.
What is Vanda?
Vanda’s catalysts are HETLIOZ and Fanapt execution, plus any regulatory or litigation update tied to the sleep franchise.
Which conditions is Vanda Pharmaceuticals targeting with Vanda?
Vanda Pharmaceuticals is associated with neuroscience based on its company overview and current catalyst commentary.
How does Vanda Pharmaceuticals describe recent progress with Vanda?
Vanda’s catalysts are HETLIOZ and Fanapt execution, plus any regulatory or litigation update tied to the sleep franchise.
What is Pharmaceuticals?
Vanda Pharmaceuticals is a specialty pharma company with an emphasis on neuroscience and sleep-related therapies.